STEVEN A SHALLCROSS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVEN A SHALLCROSS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVEN A SHALLCROSS. STEVEN A SHALLCROSS is a CEO and CFO in Synthetic Biologics, Inc. ($SYN) and a Chief Financial Officer in Synthetic Biologics, Inc. ($SYN) and a Interim CEO and CFO in Synthetic Biologics, Inc. ($SYN) and a Senior Vice President and CFO in MiddleBrook Pharmaceuticals, Inc. ($AVNC) and a Director in Newgioco Group, Inc. ($PNDR).
Address: 20425 SENECA MEADOWS PARKWAY GERMANTOWN 20876 MD
Companies in which STEVEN A SHALLCROSS is an Insider
Elys Game Technology, Corp.
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of STEVEN A SHALLCROSS: Director
Holdings: 5,245 shares
Latest Transaction: Jan 27 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MiddleBrook Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN A SHALLCROSS: Senior Vice President and CFO
Holdings: 0 shares
Latest Transaction: Feb 27 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Synthetic Biologics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN A SHALLCROSS: Interim CEO and CFO, Chief Financial Officer
Holdings: 100,000 shares
Current Value: $85,000
Latest Transaction: May 10 2021
$SYN Market Capitalization: $76.50M
$SYN Previous Close: $0.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of STEVEN A SHALLCROSS
Sentiment: All, PNDR, AVNC, SYN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Buy | P | 0.49 | 50,000 | 24,595 | 100,000 | 50 K to 100 K (+100.00 %) |
| Jan 27 2021 | PNDR | Elys Game Technolo ... | SHALLCROSS STEVEN A | Director | Grant | A | 5.72 | 5,245 | 30,001 | 5,245 | 0 to 5.2 K |
| Dec 31 2020 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Option Exercise | A | 0.42 | 450,000 | 187,650 | 450,000 | |
| Dec 05 2019 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Option Exercise | A | 0.42 | 450,000 | 188,100 | 450,000 | |
| Aug 26 2019 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Buy | P | 0.42 | 50,000 | 20,785 | 50,000 | 0 to 50 K |
| Jul 08 2019 | PNDR | Newgioco Group, In ... | SHALLCROSS STEVEN A | Director | Option Exercise | A | 0.37 | 2,500 | 925 | 82,500 | |
| Dec 07 2018 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Option Exercise | A | 0.69 | 200,000 | 137,900 | 200,000 |